Posts tagged securities law.
Blogs
2 minute read
On March 22, 2011 the U.S. Supreme Court handed down a decision which is likely to have serious repercussions for companies in the bio/pharma tech space. In MATRIXX INITIATIVES, INC., ET AL. v. SIRACUSANO ET AL., the Court rejected Matrixx argument that reports regarding the adverse effect of Zicam, its leading revenue generating product, were not statistically significant and therefore not material.
Noting that the analysis of materiality under the securities laws in fact specific, the Court appears to have relied heavily on two factors:
1. The methodologies and requirements ...
Blog Editors
Recent Updates
- Video: New H-1B Visa Fee, EEOC Shutters Disparate Impact Cases, Key Labor Roles Confirmed - Employment Law This Week
- New $100,000 H-1B Fee Proclamation – Implications and Action Steps
- Video: FTC Backs Off Non-Compete Ban, Warns Health Care Employers - Employment Law This Week
- Artificial Intelligence and Disparate Impact Liability: How the EEOC’s End to Disparate Impact Claims Affects Workplace AI
- Reminder: Massachusetts Salary Range Disclosure Requirements Take Effect in October